Bausch site 1
Rochester, New York, 14609, United States
NCT Number: NCT05325931
Experienced soft contact lens wearing subjects will be enrolled in this 1-week, confirmatory, randomized, bilateral, 2-way crossover, double masked (subject and investigator), repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria and none of the exclusion criteria, subjects will be fit and dispensed study lenses according to unique randomization schedules that will be provided to each Investigator If vision is unsatisfactory in the original dispensed lenses, additional lens powers may be trialed.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Rochester, New York, 14609, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
kalifilcon A Daily Disposable Multifocal low add and high
Ultra for Presbyopia Low and High Add Contact Lenses
Time frame: One week
Mean Binocular logMAR Visual Acuity at Distance (6m)
Time frame: One week
Mean Binocular logMAR Visual Acuity at Near (40cm)
Bausch & Lomb Incorporated
Industry
1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Contact Lenses Compared to Ultra for Presbyopia Contact Lenses
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723716
Eye Diseases, Presbyopia
Seoul, South Korea
View Trial DetailsNCT05646719
Eye Diseases, Presbyopia
Phoenix, Arizona, United States
View Trial DetailsNCT07076160
Eye Diseases, Presbyopia
Jacksonville, Florida, United States
View Trial DetailsNCT07570602
Eye Diseases, Presbyopia
Bloomington, Indiana, United States
View Trial Details